← Open Payments lookup

TRACY CLASON: Open Payments

NPI 1003991209 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$875 in 45 payments from 10 companies in 2025. Trend: 2023 $436 · 2024 $825 · 2025 $875

Food & beverage: $875
CompanyPaymentsAmount
Bausch Health US, LLC12$220
ABBVIE INC.14$214
Axsome Therapeutics, Inc.4$113
Neurocrine BioSciences, Inc.3$81
Takeda Pharmaceuticals U.S.A., Inc.3$63
Alkermes, Inc.2$58
Supernus Pharmaceuticals, Inc.3$48
Vanda Pharmaceuticals Inc.1$30
Lundbeck LLC2$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: APLENZIN, VRAYLAR, Auvelity, INGREZZA, TRINTELLIX, ARISTADA, Qelbree, FANAPT.

Industry payments across WA — which companies pay providers there.